Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. - Trepicchio,W.L.; Ozawa,M.; Walters,I.B.; Kikuchi,T.; Gilleaudeau,P.; Bliss,J.L.; Schwertschlag,U.; Dorner,A.J.; Krueger,J.G. (J Clin Invest, 1999)